aTyr Pharma, Inc.
(NASDAQ : LIFE)

( )
LIFE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.21%212.040.0%$1971.46m
BIIBBiogen, Inc. -0.67%371.901.7%$1288.80m
NVAXNovavax, Inc. -1.10%192.2479.8%$820.37m
SNSSSunesis Pharmaceuticals, Inc. -5.76%11.130.7%$778.03m
AMGNAmgen, Inc. -0.50%238.711.3%$637.40m
BNTXBioNTech SE -2.96%229.500.0%$572.94m
VRTXVertex Pharmaceuticals, Inc. -0.72%187.521.9%$527.63m
GILDGilead Sciences, Inc. -0.60%66.651.0%$475.82m
REGNRegeneron Pharmaceuticals, Inc. -0.79%529.802.7%$386.12m
ILMNIllumina, Inc. 0.74%469.133.5%$346.93m
OCGNOcugen, Inc. 2.02%7.560.0%$345.77m
ALXNAlexion Pharmaceuticals, Inc. 0.11%179.832.0%$331.72m
TXG10X Genomics, Inc. 2.16%201.410.0%$178.72m
EXASEXACT Sciences Corp. 2.37%130.9718.1%$176.05m
BNGOBionano Genomics, Inc. 1.68%7.250.0%$156.12m

Company Profile

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. Its product pipeline include ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1;DARS-1(3). The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.